Renaissance Capital logo

CNVY News

US IPO Weekly Recap: IPO market in full swing as biotechs lead a 16 IPO week

LYEL

The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL) priced at the midpoint to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and...read more

Medicare solutions provider Convey Holding prices IPO at $14 low end

CNVY

Convey Holding Parent, which provides insurers with Medicare Advantage technology and admin services, raised $187 million by offering 13.3 million shares (13% secondary) at $14, the low end of the range of $14 to $16. The company, which is also known as Convey Health, is a leading healthcare platform that utilizes technology and processes to improve government-sponsored health...read more

US IPO Week Ahead: Biotechs and software lead a 15 IPO week

LYEL

Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and epigenetic reprogramming to develop T...read more

Medicare solutions provider Convey Holding sets terms for $200 million IPO

CNVY

Convey Holding Parent, which provides Medicare-focused technology solutions and advisory services, announced terms for its IPO on Monday. The Fort Lauderdale, FL-based company plans to raise $200 million by offering 13.3 million shares (13% insider) at a price range of $14 to $16. At the midpoint of the proposed range, Convey Holding Parent would command a fully diluted market...read more